Patent ID: 11969534
Assignee: NXSTAGE MEDICAL, INC.
Field: Medical technology (Instruments)
Classification: CPC A | IPC A

Claim 0:
1. A method of performing a blood treatment without an anticoagulant, comprising:
initiating an extracorporeal blood treatment employing an initial blood treatment device, the blood treatment employing no anticoagulant;
passing blood through the initial blood treatment device and observing one or more indicators of a blood treatment device-clogging trend;
determining that the initial blood treatment device may need to be replaced responsively to said one or more indicators;
priming a replacement blood treatment device;
determining that the initial blood treatment device should be replaced responsively to said one or more indicators;
replacing the initial blood treatment device with the replacement blood treatment device primed by said priming; and
thereafter, continuing the extracorporeal blood treatment and observing so as to avoid the need for the anticoagulant.